BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2013
View Archived Issues
Zebrafish model confirms novel gene involved in the regulation of thrombocyte formation
Read More
A non-invasive, diagnostic, and prognostic method to detect successful renal transplants
Read More
Confirmation of the efficacy of a small-molecule inhibitor against a protozoan parasitic infection
Read More
Targeting factor XII for anticoagulation tested with CSL-3F7
Read More
Fab demonstrates potential for reversing dabigatran-induced anticoagulation and bleeding
Read More
Prosensa receives E.U. FP7 research grant for development of DMD candidate
Read More
Aegerion obtains European approval for Lojuxta in HoFH
Read More
TechnoVax receives NIH grant to develop universal flu vaccine
Read More
Cancer Research Technology, Institute of Cancer Research and Merck Serono form alliance
Read More
La Jolla Institute extends collaboration with KKC
Read More
Teijin Pharma and Amgen to develop novel therapies for autoimmune diseases
Read More
Bionomics and Merck & Co. to develop candidates for chronic pain
Read More
Serina Therapeutics forms research agreement with the Scripps Research Institute
Read More
Polyphor and Boehringer Ingelheim advance macrocyclic drug discovery collaboration
Read More
NIH award supports Arisaph's development of small-molecule immune modulators
Read More
OncoGenex begins phase II trial evaluating OGX-427 in NSCLC
Read More
Pivotal trial of Exparel in intercostal nerve block does not meet primary endpoint
Read More
ImmunoGen gains IND clearance from FDA for novel EGFR-targeting antibody-drug conjugate
Read More
ViroPharma discontinues phase II trial of subcutaneous Cinryze combined with rHuPH20
Read More
Daiichi Sankyo updates developments of first quarter fiscal 2013
Read More
CovX Technologies patents novel monoclonal antibody conjugates
Read More
U.S. group discloses new miRNA-196a antagonists for cancer
Read More
FDA expands age indication for Menveo quadrivalent meningococcal vaccine
Read More
